Previous Close | 109.27 |
1-Year Change | -3.22% |
6-Months Change | -8.43% |
3-Months Change | -3.66% |
Moving Avg (50d) | 106.64 |
Moving Avg (200d) | 114.51 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 22.1B |
Beta (3-Years) | 0.75 |
Revenue Growth (ttm) | 4.34% |
Net Profit Margin (ttm) | 14.27% |
Return On Assets (ttm) | 4.99% |
EPS (ttm) | 5.25 |
PE Ratio (ttm) | 20.81 |
Dividend Yield | 0.88% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol-Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011,... Wikipedia